Questex’s Fierce Biotech Announces 2025 Fierce CRO Award Finalists
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Questex’s Fierce Biotech today announces the finalists of the second annual Fierce CRO Awards.
The Fierce CRO Awards celebrate exceptional achievements and innovations by Contract Research Organizations (CROs). These awards honor CROs that have demonstrated outstanding performance, innovation, and leadership in delivering high-quality research and development services. By recognizing the excellence of CROs, the awards aim to highlight the critical role they play in advancing life sciences research and improving patient outcomes.
Fierce CRO Award finalists include:
CRO Champion Award
- Dr. Uma Sharma, Founder and CEO, MMS
- GenScript Biotech Corp
- Toyna Chin, Global Director of Marketing, Novotech
Excellence in Client Service and Partnership
- CMIC Group
- MMS
- Navitas Life Sciences
Excellence in Clinical Trial Management
- Phastar Clinical Intelligence by Phastar
- PSI CRO: The Leading CRO in Radiopharmaceutical Trial Management and Beyond by PSI CRO AG
- Trial Management Collaboration and Support for an Emerging Oncology Biotech by Catalyst Clinical Research
Excellence in Global Operations
- CTI Clinical Trial & Consulting
- Excellence in Global Operations by Crown Bioscience
- TFS HealthScience
Innovative Approaches to Patient-Centric Research
- CTI Clinical Trial & Consulting
- Empowering Patient-Centric Trials by IQVIA
- Patient-Centered Endpoints by Fortrea
Innovative Solutions in Drug Development
- BioPALS Hit Identification by Concept Life Sciences
- Centralized Monitoring for Best-In-Class Data Management by Precision for Medicine
- CertisOI Assistant: The Digital Assistant for Oncology Research by Certis Oncology Solutions
Outstanding Patient Recruitment and Retention
- Reinventing Patient Recruitment Approaches: Lindus Health's Novel Application of the Patient Identification Center (PIC) Technique by Lindus Health
- Patient recruitment and retention by Centre for Human Drug Research
- TrialWire
“Our awards program honors the outstanding performance, innovation and leadership of Contract Research Organizations in the life sciences industry. We applaud the award finalists on their work to advance research as well as the industry. We look forward to seeing who comes up on top in June,” said Rebecca Willumson, SVP and Publisher of Fierce Biotech and Fierce Pharma.
The Fierce CRO Awards finalists were judged on: Innovation and Impact, Measurable Outcomes, Sustainability and Scalability and Ethical and Regulatory Adherence.
Winners will be announced on June 18.
About Fierce Biotech
Fierce Biotech is the biotech industry's daily monitor, providing the latest news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. More than 300,000 top biotech professionals rely on Fierce Biotech for an insider briefing on the day's top stories. Signup is free here.
About Questex
Questex helps people live better and longer. Questex brings people together in the markets that help people live better: hospitality and wellness; the industries that help people live longer: life science and healthcare; and the technologies that enable and fuel these new experiences. We live in the experience economy – connecting our ecosystem through live events, surrounded by data insights and digital communities. We deliver experience and real results. It happens here.
Media Contact
Kathleen Dean
Fierce CRO Awards
kdean@questex.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
